I have to agree, really appreciate the detailed analysis here but this is already working fine in another jurisdiction, Japan and has been for years. If there is a hint of a delay it’s not a good look for the FDA IMO. Good luck msb people’s for next week . M
Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L, page-724
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
92.5¢ |
Change
-0.020(2.12%) |
Mkt cap ! $1.050B | |||
| Open | High | Low | Value | Volume |
| 93.0¢ | 93.5¢ | 92.0¢ | $1.334M | 1.441M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 30 | 153097 | 92.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 92.5¢ | 1697 | 6 |
View Market Depth
| Last trade - 14.05pm 09/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |